Apoptosis in epithelial hyperplastic laryngeal lesions

Acta Oto-Laryngologica, Supplement

Volumn , Issue 527, 1997, Pages 25-29

  Hellquist, Henrik B ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

apoptosis; bcl 2; CD95; Fas; metallothionein; TUNEL

Indexed keywords

FAS ANTIGEN; KI 67 ANTIGEN; METALLOTHIONEIN; PROTEIN BCL 2; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN;

APOPTOSIS; ARTICLE; CARCINOMA IN SITU; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; ETIOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LARYNX MUCOSA; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; CANCER INVASION; EPITHELIUM; HYPERPLASIA; LARYNX DISORDER; LARYNX TUMOR; PATHOLOGY; PRECANCER;

APOPTOSIS; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; FAS LIGAND PROTEIN; HUMANS; HYPERPLASIA; LARYNGEAL DISEASES; LARYNGEAL MUCOSA; LARYNGEAL NEOPLASMS; MEMBRANE GLYCOPROTEINS; METALLOTHIONEIN; NEOPLASM INVASIVENESS; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0030611126     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489709124029     Document Type: Article

References (14)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-57.
2. Cohen JJ. Overview: mechanisms of apoptosis. Immunol Today 1993; 14: 126-30.
3. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
4. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, van Dierendonck JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993; 41: 7-12.
5. Trauth BC, Klas C, Peters AMJ, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301-5.
6. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169: 1747-56.
7. van den Oord JJ, Sunardhi-Widyaputra S, Van Damme B, De Ley M. Monoclonal antibody to liver metallothionein: a novel marker for myoepithelial cells. Pathol Res Pract 1993; 189: 1187-90.
8. Buttke TM, Sandstrsm PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10.
9. Kambic V, Gale N. Epithelial hyperplastic lesions of the larynx. Amsterdam: Elsevier, 1995.
10. Miyashita T, Krajewski S, Krajewski M, et al. Tumor suppressor p53 is a regulator of bcl-2 and box gene expression in vitro and in vivo. Oncogene 1994; 9: 1799-805.
11. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293-9.
12. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC, Raff MC. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 1993; 361: 365-9.
13. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75: 241-51.
14. KSgi JHR. Overview of metallothionein. In: Riordan JF, Vallee BL, eds. Methods in enzymology. Vol. 205. San Diego: Academic Press, 1991; 613-26.